Trezix - 66992-340-10 - (acetaminophen, caffeine, dihydrocodeine bitartrate)

Alphabetical Index


Drug Information of Trezix

Product NDC: 66992-340
Proprietary Name: Trezix
Non Proprietary Name: acetaminophen, caffeine, dihydrocodeine bitartrate
Active Ingredient(s): 320.5; 30; 16    mg/1; mg/1; mg/1 & nbsp;   acetaminophen, caffeine, dihydrocodeine bitartrate
Administration Route(s): ORAL
Dosage Form(s): CAPSULE
Coding System: National Drug Codes(NDC)

Labeler Information of Trezix

Product NDC: 66992-340
Labeler Name: WraSer LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA040688
Marketing Category: ANDA
Start Marketing Date: 20090901

Package Information of Trezix

Package NDC: 66992-340-10
Package Description: 100 CAPSULE in 1 BOTTLE (66992-340-10)

NDC Information of Trezix

NDC Code 66992-340-10
Proprietary Name Trezix
Package Description 100 CAPSULE in 1 BOTTLE (66992-340-10)
Product NDC 66992-340
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name acetaminophen, caffeine, dihydrocodeine bitartrate
Dosage Form Name CAPSULE
Route Name ORAL
Start Marketing Date 20090901
Marketing Category Name ANDA
Labeler Name WraSer LLC
Substance Name ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
Strength Number 320.5; 30; 16
Strength Unit mg/1; mg/1; mg/1
Pharmaceutical Classes Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient],Full Opioid Agonists [MoA],Opioid Agonist [EPC]

Complete Information of Trezix


General Information